Edward J. Dulac III
EVP, Chief Financial Officer at Intellia Therapeutics · 5 reported transactions in 1 company · latest trade Jul 22, 2026
Their trades
Sold | Jul 22, 2026 | Jul 22, 2026 close $11.13 → Oct 28, 2026 close $13.32. S&P 500 +3.0% over the same days. | ||
Sold | Jul 2, 2026 | Jul 2, 2026 close $17.56 → Oct 28, 2026 close $13.32. S&P 500 +3.3% over the same days. | ||
Sold | Jan 5, 2026 | Jan 5, 2026 close $9.37 → Oct 28, 2026 close $13.32. S&P 500 +11.9% over the same days. | ||
Sold | Jul 23, 2025 | Jul 23, 2025 close $14.24 → Oct 28, 2026 close $13.32. S&P 500 +21.4% over the same days. |
$91.2K
Jul 22, 2026 close $11.13 → Oct 28, 2026 close $13.32. S&P 500 +3.0% over the same days.
$84.2K
Jul 2, 2026 close $17.56 → Oct 28, 2026 close $13.32. S&P 500 +3.3% over the same days.
$58.8K
Jan 5, 2026 close $9.37 → Oct 28, 2026 close $13.32. S&P 500 +11.9% over the same days.
$104.6K
Jul 23, 2025 close $14.24 → Oct 28, 2026 close $13.32. S&P 500 +21.4% over the same days.